chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swelling around the injection site; arm soreness; Pain; redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), VACCINATION SITE PAIN (Pain), VACCINATION SITE ERYTHEMA (redness around the injection site) and VACCINATION SITE SWELLING (Swelling around the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 1. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm soreness), VACCINATION SITE PAIN (Pain) and VACCINATION SITE ERYTHEMA (redness around the injection site). On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling around the injection site). At the time of the report, PAIN IN EXTREMITY (arm soreness), VACCINATION SITE PAIN (Pain) and VACCINATION SITE ERYTHEMA (redness around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided by the reporter. No treatment medication was provided by the reporter.
Pt received vaccines, waited in the allotted waiting area after getting vaccines. Pt brought back to exam room after experiencing vasovagal reaction. Pt was placed in dorsal recumbent position and given an ice pack that was placed under the neck.
After a few hours and for about 2 days,  Headache, Fatigue and low-grade fever.
Immediately after giving MMRV vaccine this RN noticed an area about half an inch away from injection site appearing to bubble in 2 - 3 places. The bubbles quickly coalesced into one larger bubble. The shape of the lesion was like a goldfish cracker with dimpled skin. It measured about 1 inch long and was half an inch wide at its widest point. Drs examined the lesion. Listened to her haert and lungs and advised that we watch child for possible allergic reaction. The area was drawn around with a black ballpoint and it did not increase in length or width. Pt was discharged at 11:15 AM after the providers had examined her again. The lesion was not as swollen but was still firm. (The height of the area had gone down). Patient remained conscious throughout and denied pain or itching or other symptoms.
middle finger is swollen; her left hand started giving her a lot of pain on her middle finger and the fingers on either side of the middle finger; she can't fully grip like she usually did previous to that; middle finger is stiff she can't bend it all the way or straighten it all the way; This is a spontaneous report from a contactable consumer (patient) reported for self via Medical Information Team. A 59-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3249 and Expiry date: May2021), via unspecified route of administration on Left arm on 18Jan2021 at a single dose for covid-19 immunisation. The patient medical history was none. Concomitant medications were not reported. The patient reported that, she originally got the first vaccine in Jan. She is trying to find her paper with the dates on it. She says she got it on 18Jan2021 and she knows joint discomfort is one of the things she saw on the paperwork. She was okay until 27Jan2021 then her left hand started giving her a lot of pain on her middle finger and the fingers on either side of the middle finger and it still sore she can't fully grip like she usually did previous to that on 27Jan2021. She wondered if that could be a symptom or something from the vaccine. She contacted her hospital and it had a recording that said if this is an emergency go to the ER if it is something else call your family which she did doctor but she is wondering she has the second dose and she is wondering if she should go ahead and get the second dose she feels like they will probably put it in her left arm again. she uses her hands every day to work and that is a concern. She says it was pain in her middle finger, it was swollen and the fingers on either side and they were hard to open and close and it is ongoing at this time on 27Jan2021. It feels little better at times then it starts hurting again. It is not as bad as the first day it started but her middle finger is stiff she can't bend it all the way or straighten it all the way on 27Jan2021. She is very healthy she has had no other issues with it. Nothing else has happened to her hand. She was just at work one day the 27Jan2021 and she could hardly open and close her hand at work. Patient did not have investigation assessment. The outcome of the events was not recovered.  No follow-up attempts needed. No further information expected.
Itchy; Large red patches about 2&1/2 inches in diameter; painful(3 on scale of 1-10), .; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy), RASH ERYTHEMATOUS (Large red patches about 2&1/2 inches in diameter) and RASH (painful(3 on scale of 1-10), .) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (Itchy), RASH ERYTHEMATOUS (Large red patches about 2&1/2 inches in diameter) and RASH (painful(3 on scale of 1-10), .). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (Itchy), RASH ERYTHEMATOUS (Large red patches about 2&1/2 inches in diameter) and RASH (painful(3 on scale of 1-10), .) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
On 28FEB92 pt exp fatigue, muscle & joint aches & pains w/generalized, nausea, dec appetite, shaking, chills; on 29FEB92 all sx inc in severity in addtl vomiting & diarrhea devel;
Fever (101.8), body aches, chills onset about 8 hours after injection. Treated successfully with nsaid
This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a adult male patient who received DTPa vaccine. Concurrent medical conditions included allergy. On an unknown date, the patient received DTPa vaccine at an unknown dose. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced sickness, lethargy, crying, movement disorder, appetite absent and fear. On an unknown date, the outcome of the sickness, lethargy, crying, movement disorder, appetite absent and fear were unknown. It was unknown if the reporter considered the sickness, lethargy, crying, movement disorder, appetite absent and fear to be related to DTPa vaccine. Additional details were provided as follows: This case was reported by the patient's parent. The age at vaccination was not reported. The patient who was in his mid-30s was allergic. The patient was so very sick from the shot. He was so lethargic and did not move for three days just cried and would not eat scared the hell out of us. The physician were afraid to give our other two children the same shots when they were old enough. They did get DT shots, just not the Dpt.
Woke up with severe chills, low fever, nausea, headache. Sick about 24 hours. 2 days later got very dizzy and shaky had to sit most of the day.
I experienced fever runny nose and a sore throat, I went home and tested positive with a home test. I called my Doctor who prescribed medication, Paxlovid.
Significant swelling and redness at the site. Mom reports that initially the biceps area where he received vaccine had redness the size of a softball- and following that the entire arm swelling, even down to his wrist/hand.
After both DTAP 1 and DTAP 2 at 2 months and 4 months of age, pt experienced prolonged fever and irritability (X 7 days) with symptoms worse after DTAP 2. DTAP 1 lot 966A2/IM/RMLT.
Sore achy body. Fever 101.2. Starting around 8pm the night of the shot. Then nearly 24hrs later, Nausea, diarrhea. Headache and sore arm at jab site
"Pfizer-BioNTech COVID - 19 Vaccine EUA"     Patient's pupils are dilated, light sensitive.
Rash, tingling (pins and needles) about a week after shot. Treatment possible acyclovir tabs and Caspsaicin cm.
Received 1st dose of Pfizer on 10/1/2021. Symptoms developed on 10/8/2021.  Eight days after receiving the vaccine, my throat began swelling. I developed  extremely swollen eyes and  itchy rashes formed on eyelids. A itchy rash appeared on the front of my neck, stretching from ear to ear, under chin to base of neck. Lymph nodes in neck and jaw became swollen. Itchiness developed around mouth. Developed fatigue. Had a headache and body aches, nausea and upper part of lungs hurt. Still experiencing symptoms.   Went to medical facility. Received 5 day prescription of prednisone (started taking 10/13/2021). Taking Claritin during day and Benadryl at night. Using Benadryl cream on rashes. Taking inhaler (albuterol sulfate) to aid lung pain.   Symptoms are still occurring, rash has started to fade and swelling has gone down. Lung pain and fatigue continues
chills; fever up to 102; diarrhea; This is a spontaneous report from a contactable other healthcare professional (HCP, patient herself). A 63-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection; lot number: ek5730, expiration date: unknown), intramuscularly on the right arm on 18Dec2020 at 16:15 at a single dose for COVID-19 immunization administered at the hospital. The patient's medical history and concomitant medications were not reported. The patient previously took codeine, for which she had known allergies. The patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Dec2020 at 19:00, the patient experienced chills, fever up to 102, and diarrhea. The reporter assessed the events as non-serious. Therapeutic measures were taken as a result of chills, fever up to 102, and diarrhea as she talked to her family physician. The patient recovered from all the events on an unspecified date.
My husband was 42-year-old male with past medical history of ADHD who initially presented to local Medical Center hospital on 04/02 with frequent falls, right arm weakness and altered mental status. Was found to have acute intraparenchymal hemorrhage with surrounding edema in the rt occipital lobe, subsequently was intubated for airway protection, course was complicated by worsening shock requiring vasopressors and transferred to alternate hospital for further care. Patient was dealing with atraumatic back pain since March 2022, eventually obtained an MRI on 03/25/2022 which showed spinal pelvic lesions, and was referred to the cancer center, and a bone marrow biopsy was performed on 03/30/22.
Community outreach completed at Nursing Home. Consents signed by Nursing Home administrators/guardians for patient to receive vaccine. Health Center staff thought nursing home had record of primary dose series of covid vaccine that was not entered to show me vax. Bivalent dose given as error that now, per CDC recommendations will serve as the "1st dose" and vaccine series will be completed correctly
Approx 16 days following vaccine patient's Sp02 saturation dropped to 70-80% despite being on 6liters O2
Within 5 minutes of injection, tightness in chest and throat lasting a few minutes. As day progressed lost appetite and felt ill. Later severe headache and fever. Body aches, sweating lasted 3 days with less severe symptoms each day.
Initial report received from a health care professional on 05-Nov-2013. A female received FLUZONE HD (batch number, expiry date and route were unknown). The patient's medical history and concomitant medications were not reported. Immediately after the vaccination the patient experienced diarrhea and throat itching. At the time of this report the outcome of the events was unknown. Documents held by sender: none
Client received Jansen Covid 19 vaccine and on her way out she was seen passing out on the floor, she was caught and lowered to the ground. Client did not lose consciousness and reports feeling nauseous, she states that she usually passes out when her blood is drawn. Her lying BP was 106/68 p54, sitting BP is 116/81 p 74, standing BP 116/76.  She started to vomit and 911 was called. Medic 203 responded and arrived at 12:30, IV line was stablished and client was transported to the hospital.
Not feeling well; Face feel hot; Rash; Fever with high temperature; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well), FEELING HOT (Face feel hot), RASH (Rash) and PYREXIA (Fever with high temperature) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     no medical history was provided by reporter.  Concomitant products included ANASTROZOLE for an unknown indication.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 12-Mar-2021, the patient experienced PYREXIA (Fever with high temperature). On 15-Mar-2021, the patient experienced MALAISE (Not feeling well), FEELING HOT (Face feel hot) and RASH (Rash). At the time of the report, MALAISE (Not feeling well), FEELING HOT (Face feel hot) and PYREXIA (Fever with high temperature) had resolved and RASH (Rash) had not resolved.            No treatment information was provided. Action taken with mRNA-123 is not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: follow up was received on 24 may 2021 patient stated about event duration and outcome of the events was updated
Nausea - patient feeling nervous after vaccine. After getting fresh air, patient condition improved. Patient refused transport. Medical assessment findings within normal limits.
injection site pain; shaking; This case was reported by a physician via sales rep and described the occurrence of injection site pain in a 16-year-old male patient who received Men B NVS (Bexsero) (batch number ABXA32AA, expiry date May 2021) for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero. On an unknown date, less than a day after receiving Bexsero, the patient experienced injection site pain and tremor. On an unknown date, the outcome of the injection site pain and tremor were unknown.   It was unknown if the reporter considered the injection site pain and tremor to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced injection site pain and shaking after arriving back at home.
Right side of his neck is feeling tense; His right hand pinky; His right hand is starting to tingle; His right hand feel slightly numb; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Right side of his neck is feeling tense), SKIN DISCOLOURATION (His right hand pinky), PARAESTHESIA (His right hand is starting to tingle) and HYPOAESTHESIA (His right hand feel slightly numb) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022T21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2022, the patient experienced MUSCULOSKELETAL STIFFNESS (Right side of his neck is feeling tense), SKIN DISCOLOURATION (His right hand pinky), PARAESTHESIA (His right hand is starting to tingle) and HYPOAESTHESIA (His right hand feel slightly numb). At the time of the report, MUSCULOSKELETAL STIFFNESS (Right side of his neck is feeling tense), SKIN DISCOLOURATION (His right hand pinky), PARAESTHESIA (His right hand is starting to tingle) and HYPOAESTHESIA (His right hand feel slightly numb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.
Fever averaging 104F for 3 months solid. Loss of social skills, and all language. Seemed to lose memory. Developed seizure disorder. Has high count of floura-Aluminate and Mercury. Immune therapy (breastmilk & T.F.) are helping. 60 day follow-up states the pt still has seizure activity, severe disabilities, digestive disorders, immune system disorder, autoimmune problems.
Dose 1- 16-Jun-2021 Dose 2- 04-Aug-2021; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1- 16-Jun-2021 Dose 2- 04-Aug-2021) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included MULTIVITAMIN IRON for an unknown indication.   On 16-Jun-2021 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Aug-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 04-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1- 16-Jun-2021 Dose 2- 04-Aug-2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1- 16-Jun-2021 Dose 2- 04-Aug-2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was prescribed with some medications after third dose. Those are hydrochlorothiazide 25 mg tablet, hydrocodone 10 mg with acetaminophen 325 mg tablet, methocarbamol 750 mg tablet, naproxen 500 mg tablet. The patient had no known drug allergies. No treatment medications were reported.   This case was linked to MOD-2022-544255 (Patient Link).
Total body itch with some skin reaction.  Continuous throughout day and night. Initially from head (scalp) to knees (Front and Back) and then eventually entire legs.
Rash - erythematous papular in large patches on the torso. Body aches, headache, fatigue.
two-part shot, still break out with them/suspected vaccination failure; still break out with them; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 26-Mar-2022 Reporter's Comments: This case was reported by a consumer via interactive digital media. The reporter stated, it did not matter if you get the two-part shot, the patients still broke out with shingles. Additional Supportive Information: This case described the occurrence of suspected  vaccination failure. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not be possible, as no contact details were available. This case had been linked to US2022AMR056641, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR056641:Same reporter
The night after the vaccination the patient had swelling and redness in the left thigh and a temperature of 106F which subsequently resolved with ibuprofen. No other serious problems occurred.
Patient called medical facility to report Migraine, weakness, fever (highest temp was 102), and nausea/vomitting that began the day after her vaccination. She stated these symptoms lasted approx 4 days and fever finally broke today. She also stated that approx 2 days after vaccination, she began having pain in her Left Leg and soreness to her L foot. She denied any injuries to extremity. She stated that her left arm was sore (vaccine was administered in her L deltoid) but stated that there was no redness or swelling to site. RN counseled patient on usual side effects related to Tdap vaccination and advised patient to see PCP regarding pain/soreness to L leg/L foot. Patient verbalized understanding and agreed to contact medical facility to update on status if seen by PCP.
Many Muscle spasm's  in both feet and upper calf.  Numbness in right foot on top near last two toes 24 hours after second shot. it is now 6 months later and I still have those symptoms.
Redness and swelling around injection site, arm is "tight". Area is warm to touch even 3 days post administration. Pt. is complaining of feeling low in energy.